{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo+inhaler&page=7", "query": { "intervention": "placebo inhaler", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 298, "total_pages": 30, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo+inhaler&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo+inhaler&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T14:34:38.517Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03110900", "title": "Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Agitation,Psychomotor", "Haloperidol Causing Adverse Effects in Therapeutic Use", "Lorazepam Causing Adverse Effects in Therapeutic Use", "Loxapine Causing Adverse Effects in Therapeutic Use" ], "interventions": [ { "name": "Haloperidol + lorazepam", "type": "DRUG" }, { "name": "Loxapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Arkansas", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 2, "start_date": "2017-09-30", "completion_date": "2018-04-04", "has_results": true, "last_update_posted_date": "2018-06-11", "last_synced_at": "2026-11-15T14:34:38.517Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03110900" }, { "nct_id": "NCT01845025", "title": "Study of Safety of Foradil in Patients With Persistent Asthma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Persistent Asthma" ], "interventions": [ { "name": "Formoterol 12 mcg", "type": "DRUG" }, { "name": "Fluticasone propionate 100 mcg", "type": "DRUG" }, { "name": "Fluticasone propionate 250 mcg", "type": "DRUG" }, { "name": "Fluticasone propionate 500 mcg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 827, "start_date": "2013-05", "completion_date": "2016-05", "has_results": true, "last_update_posted_date": "2017-03-21", "last_synced_at": "2026-11-15T14:34:38.517Z", "location_count": 27, "location_summary": "Avondale, Arizona • North Hollywood, California • Bradenton, Florida + 21 more", "locations": [ { "city": "Avondale", "state": "Arizona" }, { "city": "North Hollywood", "state": "California" }, { "city": "Bradenton", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01845025" }, { "nct_id": "NCT01336608", "title": "A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Fluticasone Furoate/Vilanterol", "type": "DRUG" }, { "name": "Vilanterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 446, "start_date": "2011-03-04", "completion_date": "2014-11-04", "has_results": true, "last_update_posted_date": "2017-11-08", "last_synced_at": "2026-11-15T14:34:38.517Z", "location_count": 36, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Newport Beach, California + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "DeLand", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01336608" }, { "nct_id": "NCT01181895", "title": "Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Vilanterol", "type": "DRUG" }, { "name": "Salmeterol Inhalation Powder", "type": "DRUG" }, { "name": "Placebo Inhalation Powder NDPI", "type": "DRUG" }, { "name": "Placebo Inhalation Powder Diskus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 348, "start_date": "2010-09-01", "completion_date": "2011-08-26", "has_results": true, "last_update_posted_date": "2017-11-08", "last_synced_at": "2026-11-15T14:34:38.517Z", "location_count": 11, "location_summary": "Huntington Beach, California • Orlando, Florida • Tallahassee, Florida + 8 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tallahassee", "state": "Florida" }, { "city": "Lawrenceville", "state": "Georgia" }, { "city": "Skillman", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01181895" }, { "nct_id": "NCT06504446", "title": "Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Refractory or Unexplained Chronic Cough" ], "interventions": [ { "name": "NOC-110", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Nocion Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 455, "start_date": "2024-09-24", "completion_date": "2026-06-29", "has_results": false, "last_update_posted_date": "2026-06-11", "last_synced_at": "2026-11-15T14:34:38.517Z", "location_count": 68, "location_summary": "Foley, Alabama • Scottsdale, Arizona • Tempe, Arizona + 60 more", "locations": [ { "city": "Foley", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06504446" }, { "nct_id": "NCT07481981", "title": "A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Arterial Hypertension" ], "interventions": [ { "name": "Treprostinil Palmitil Inhalation Powder", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Insmed Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 344, "start_date": "2026-07-21", "completion_date": "2029-01-28", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-11-15T14:34:38.517Z", "location_count": 11, "location_summary": "Los Angeles, California • Santa Barbara, California • Torrance, California + 7 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Santa Barbara", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT07481981" }, { "nct_id": "NCT03622112", "title": "A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "AZD7594 DPI 55μg/50μg.", "type": "DRUG" }, { "name": "AZD7594 DPI 99 µg/90 µg", "type": "DRUG" }, { "name": "AZD7594 DPI 198 µg/180 µg", "type": "DRUG" }, { "name": "AZD7594 DPI 396 µg/360 µg once daily.", "type": "DRUG" }, { "name": "AZD7594 DPI 792 µg/720 µg", "type": "DRUG" }, { "name": "Placebo for AZD7594 once daily.", "type": "DRUG" }, { "name": "FF 100 µg once daily (open-label)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 808, "start_date": "2019-01-02", "completion_date": "2019-09-30", "has_results": true, "last_update_posted_date": "2020-11-27", "last_synced_at": "2026-11-15T14:34:38.517Z", "location_count": 21, "location_summary": "Sheffield, Alabama • Phoenix, Arizona • Fullerton, California + 18 more", "locations": [ { "city": "Sheffield", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fullerton", "state": "California" }, { "city": "Gold River", "state": "California" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03622112" }, { "nct_id": "NCT02845752", "title": "The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Stiolto Respimat", "type": "DRUG" }, { "name": "Placebo Respimat", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "45 Years to 90 Years" }, "enrollment_count": 14, "start_date": "2017-03-01", "completion_date": "2018-08-06", "has_results": true, "last_update_posted_date": "2020-08-06", "last_synced_at": "2026-11-15T14:34:38.517Z", "location_count": 1, "location_summary": "Torrance, California", "locations": [ { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02845752" }, { "nct_id": "NCT01472757", "title": "Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "VR506", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vectura Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "12 Years to 65 Years" }, "enrollment_count": 374, "start_date": "2011-10", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2020-04-21", "last_synced_at": "2026-11-15T14:34:38.517Z", "location_count": 32, "location_summary": "Fountain Valley, California • Los Angeles, California • Mission Viejo, California + 28 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Rancho Mirage", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01472757" }, { "nct_id": "NCT01634139", "title": "Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Tiotropium low dose QD", "type": "DRUG" }, { "name": "Tiotropium high dose QD", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 403, "start_date": "2012-07", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2016-07-12", "last_synced_at": "2026-11-15T14:34:38.517Z", "location_count": 6, "location_summary": "Columbia, Missouri • Cincinnati, Ohio • Oklahoma City, Oklahoma + 3 more", "locations": [ { "city": "Columbia", "state": "Missouri" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Charleston", "state": "South Carolina" }, { "city": "Arlington", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01634139" } ] }